A new contrast medium for cholangio-cholecystography: meglumine iodoxamete.
A preliminary study of 18 patients following a single bolus intravenous injection of 10 to 30 cc. of meglumine iodoxamate (Cholovue), a new contrast medium for cholangio-cholecystography, showed no significant adverse clinical or laboratory effects with 10 to 20 cc., and only transient, minor changes with 30 cc. Early and persistent visucalization of the subsegmented and major bile ducts and the gallbladder was obtained. Good to excellent opacification was obtained in all cases with doses ranging between 0.11 cc./kg. (19.7 mg. iodine) to 0.59 cc./kg. (108 mg. iodine). Meglumine iodoxamate appears to be highly effective agent for cholangio-cholecystography.
D000293:Adolescent; D000328:Adult; D055598:Chemical Phenomena; D002621:Chemistry; D002758:Cholangiography; D002765:Cholecystography; D005260:Female; D006801:Humans; D007463:Iodobenzoates; D008297:Male; D008875:Middle Aged; D014283:Triiodobenzoic Acids
D007463:Iodobenzoates; D014283:Triiodobenzoic Acids